Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC) – an investigation in a department of surgical medicine

Author： Farker Katrin Schotte Uwe Scheele Johannes Hoffmann Annemarie

Publisher： Urban & Fischer

ISSN： 0940-2993

Source： Experimental and Toxicologic Pathology, Vol.54, Iss.5-6, 2003-05, pp. : 387-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Polymorphism in N-Acetyltransferase (NAT): Population Distribution of NAT1 and NAT2 Activity

By Walker Katy

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 440-472

Taylor & Francis Ltd

Access to resources Recommend Favorite

Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences

By Guo Wei Chao Lin Guo Fang Chen Ji Gang Golka Klaus Shen Jian Hua

Archives of Toxicology, Vol. 78, Iss. 8, 2004-08 ,pp. : 425-429

Springer Publishing Company

Access to resources Recommend Favorite

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

By Donald P. Parkin D. Seifart H. Schaaf H. Helden P. Werely C. Sirgel F. Venter A. Maritz J.

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 633-639

Springer Publishing Company

Access to resources Recommend Favorite

Structure/Function Evaluations of Single Nucleotide Polymorphisms in Human N-Acetyltransferase 2

Current Drug Metabolism, Vol. 9, Iss. 6, 2008-07 ,pp. : 471-486

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of Arylamine N-acetyltransferase

Current Pharmacogenomics, Vol. 2, Iss. 3, 2004-09 ,pp. : 219-231

Bentham Science Publishers

Access to resources Recommend Favorite